These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52 related articles for article (PubMed ID: 8960564)
1. Synthesis and in vitro evaluation of new wortmannin esters: potent inhibitors of phosphatidylinositol 3-kinase. Creemer LC; Kirst HA; Vlahos CJ; Schultz RM J Med Chem; 1996 Dec; 39(25):5021-4. PubMed ID: 8960564 [TBL] [Abstract][Full Text] [Related]
2. Studies on the mechanism of phosphatidylinositol 3-kinase inhibition by wortmannin and related analogs. Norman BH; Shih C; Toth JE; Ray JE; Dodge JA; Johnson DW; Rutherford PG; Schultz RM; Worzalla JF; Vlahos CJ J Med Chem; 1996 Mar; 39(5):1106-11. PubMed ID: 8676346 [TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo antitumor activity of the phosphatidylinositol-3-kinase inhibitor, wortmannin. Schultz RM; Merriman RL; Andis SL; Bonjouklian R; Grindey GB; Rutherford PG; Gallegos A; Massey K; Powis G Anticancer Res; 1995; 15(4):1135-9. PubMed ID: 7653991 [TBL] [Abstract][Full Text] [Related]
4. Effects of wortmannin analogs on bone in vitro and in vivo. Sato M; Bryant HU; Dodge JA; Davis H; Matter WF; Vlahos CJ J Pharmacol Exp Ther; 1996 Apr; 277(1):543-50. PubMed ID: 8613966 [TBL] [Abstract][Full Text] [Related]
5. Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase. Powis G; Bonjouklian R; Berggren MM; Gallegos A; Abraham R; Ashendel C; Zalkow L; Matter WF; Dodge J; Grindey G Cancer Res; 1994 May; 54(9):2419-23. PubMed ID: 8162590 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of fluorescent derivatives of wortmannin and demethoxyviridin as probes for phosphatidylinositol 3-kinase. Giner JL; Kehbein KA; Cook JA; Smith MC; Vlahos CJ; Badwey JA Bioorg Med Chem Lett; 2006 May; 16(9):2518-21. PubMed ID: 16464575 [TBL] [Abstract][Full Text] [Related]
7. Wortmannin, a phosphoinositide 3-kinase inhibitor, selectively enhances cytotoxicity of receptor-directed-toxin chimeras in vitro and in vivo. Davol PA; Bizuneh A; Frackelton AR Anticancer Res; 1999; 19(3A):1705-13. PubMed ID: 10470104 [TBL] [Abstract][Full Text] [Related]
8. Different pathways of inhibitory effects of wortmannin on exocytosis are revealed by video-enhanced light microscope. Ozawa K; Masujima T; Ikeda K; Kodama Y; Nonomura Y Biochem Biophys Res Commun; 1996 May; 222(2):243-8. PubMed ID: 8670190 [TBL] [Abstract][Full Text] [Related]
9. Phosphatidylinositol 3-kinase inhibitor wortmannin blocks mitogenic activation of the transferrin receptor gene promoter in late G1. Miskimins WK; King F; Miskimins R Cell Growth Differ; 1997 May; 8(5):565-70. PubMed ID: 9149907 [TBL] [Abstract][Full Text] [Related]
10. Advances with phospholipid signalling as a target for anticancer drug development. Powis G; Berggren M; Gallegos A; Frew T; Hill S; Kozikowski A; Bonjouklian R; Zalkow L; Abraham R; Ashendel C Acta Biochim Pol; 1995; 42(4):395-403. PubMed ID: 8852330 [TBL] [Abstract][Full Text] [Related]
11. Wortmannin, a phosphatidylinositol 3-kinase inhibitor, blocks antigen-mediated, but not CD3 monoclonal antibody-induced, activation of murine CD4+ T cells. Shi J; Cinek T; Truitt KE; Imboden JB J Immunol; 1997 May; 158(10):4688-95. PubMed ID: 9144481 [TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor stimulation of phosphatidylinositol 3-kinase during wound closure in rabbit corneal epithelial cells. Zhang Y; Akhtar RA Invest Ophthalmol Vis Sci; 1997 May; 38(6):1139-48. PubMed ID: 9152233 [TBL] [Abstract][Full Text] [Related]
13. Involvement of stress-activated protein kinase in the cellular response to 1-beta-D-arabinofuranosylcytosine and other DNA-damaging agents. Saleem A; Datta R; Yuan ZM; Kharbanda S; Kufe D Cell Growth Differ; 1995 Dec; 6(12):1651-8. PubMed ID: 9019171 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of synthetic viridins derived from C(20)-heteroalkylation of the steroidal PI-3-kinase inhibitor wortmannin. Wipf P; Minion DJ; Halter RJ; Berggren MI; Ho CB; Chiang GG; Kirkpatrick L; Abraham R; Powis G Org Biomol Chem; 2004 Jul; 2(13):1911-20. PubMed ID: 15227545 [TBL] [Abstract][Full Text] [Related]
15. Tyrosine phosphorylation of insulin receptor substrate-1 and activation of the PI-3-kinase pathway by glycine-extended gastrin precursors. Kowalski-Chauvel A; Pradayrol L; Vaysse N; Seva C Biochem Biophys Res Commun; 1997 Jul; 236(3):687-92. PubMed ID: 9245714 [TBL] [Abstract][Full Text] [Related]
16. Differential effects of EGF and amphiregulin on adhesion molecule expression and migration of colon carcinoma cells. Solic N; Davies DE Exp Cell Res; 1997 Aug; 234(2):465-76. PubMed ID: 9260917 [TBL] [Abstract][Full Text] [Related]
17. CD40-triggered protein tyrosine phosphorylation on Vav and on phosphatidylinositol 3-kinase correlates with survival of the Ramos-Burkitt lymphoma B cell line. Padmore L; An S; Gunby RH; Kelly K; Radda GK; Knox KA Cell Immunol; 1997 May; 177(2):119-28. PubMed ID: 9178638 [TBL] [Abstract][Full Text] [Related]
18. Phosphatidylinositol 3'-kinase is required for growth of mast cells expressing the kit catalytic domain mutant. Shivakrupa R; Bernstein A; Watring N; Linnekin D Cancer Res; 2003 Aug; 63(15):4412-9. PubMed ID: 12907613 [TBL] [Abstract][Full Text] [Related]
19. A multiwell assay for inhibitors of phosphatidylinositol-3-kinase and the identification of natural product inhibitors. Frew T; Powis G; Berggren M; Abraham RT; Ashendel CL; Zalkow LH; Hudson C; Qazia S; Gruszecka-Kowalik E; Merriman R Anticancer Res; 1994; 14(6B):2425-8. PubMed ID: 7872663 [TBL] [Abstract][Full Text] [Related]
20. Prosaposin: a new player in cell death prevention of U937 monocytic cells. Misasi R; Garofalo T; Di Marzio L; Mattei V; Gizzi C; Hiraiwa M; Pavan A; Grazia Cifone M; Sorice M Exp Cell Res; 2004 Aug; 298(1):38-47. PubMed ID: 15242760 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]